Replies to post #457549 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

I will not sell any here.

As aggravating/upsetting as the stock price situation is, I have not had a single thought about selling at this late juncture. The problem for me is resisting adding shares at the current or an even lower price. Like you, I await ongoing MAA process in Europe, feedback that will inevitably come from the FDA, and the outcome of the open label extension trial. Meanwhile, a year from now the 3-71 Phase 2 schizophrenia trial will product some trial data.